NORTH BILLERICA, Mass.–(BUSINESS WIRE)– Lantheus
Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus
Medical Imaging, Inc. (“LMI”), today announced that Mary Anne Heino,
President and Chief Executive Officer, and Jack Crowley, Chief Financial
Officer, will present at the 2017 Cantor Fitzgerald Global Healthcare
Conference on Tuesday, September 26 at 1:40 p.m. Eastern Time. The
conference will be held at the InterContinental New York Barclay Hotel
in New York City.
To access a live webcast of the presentation, please visit the Investors
section of the Company’s website at www.lantheus.com.
A replay of the webcast will be available on the Company’s website for
30 days following the live presentation.
About Lantheus Holdings, Inc. and Lantheus Medical Imaging, Inc.
Lantheus
Holdings, Inc. is the parent company of LMI, a global leader in the
development, manufacture and commercialization of innovative diagnostic
imaging agents and products. LMI provides a broad portfolio of products,
including the echocardiography contrast agent DEFINITY® Vial
for (Perflutren Lipid Microsphere) Injectable Suspension; TechneLite®
(Technetium Tc99m Generator), a technetium-based generator that provides
the essential medical isotope used in nuclear medicine procedures; and
Xenon (Xenon Xe 133 Gas), an inhaled radiopharmaceutical imaging agent
used to evaluate pulmonary function and for imaging the lungs. The
Company is headquartered in North Billerica, Massachusetts with offices
in Puerto Rico and Canada. For more information, visit www.lantheus.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170913006358/en/
Contacts
Lantheus Holdings, Inc.
Meara Murphy, 978-671-8508
Director,
Investor Relations & Corporate Communications
or
Gary
Santo, 978-671-8960
Head of Capital Markets & Investor Relations
Source: Lantheus Holdings, Inc.
Cet article Lantheus Holdings, Inc. to Present at 2017 Cantor Fitzgerald Global
Healthcare Conference est apparu en premier sur EEI-BIOTECHFINANCES.